Healthcare provider profile · identity verified

Cristina Ann Custer, NP

Nurse Practitioner · MAUSTON, WI · NPI 1548241821

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	545	138
Amlodipine Besylate	Amlodipine Besylate	528	117
Levothyroxine Sodium	Levothyroxine Sodium	380	74
Losartan Potassium	Losartan Potassium	293	60
Metoprolol Succinate	Metoprolol Succinate	253	66
Potassium Chloride	Potassium Chloride	248	44
Gabapentin	Gabapentin	237	38
Lisinopril	Lisinopril	189	45
Sertraline Hcl	Sertraline Hcl	176	39
Duloxetine Hcl	Duloxetine Hcl	175	37
Omeprazole	Omeprazole	171	52
Eliquis	Apixaban	152	36
Metoprolol Tartrate	Metoprolol Tartrate	146	26
Furosemide	Furosemide	130	33
Metformin Hcl	Metformin Hcl	128	26
Spironolactone	Spironolactone	123	21
Trazodone Hcl	Trazodone Hcl	116	20
Pantoprazole Sodium	Pantoprazole Sodium	115	27
Lorazepam	Lorazepam	107	23
Hydrochlorothiazide	Hydrochlorothiazide	104	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	94	21
Rosuvastatin Calcium	Rosuvastatin Calcium	94	23
Mirtazapine	Mirtazapine	93	13
Metformin Hcl Er	Metformin Hcl	91	18
Albuterol Sulfate Hfa	Albuterol Sulfate	90	35
Famotidine	Famotidine	89	26
Tamsulosin Hcl	Tamsulosin Hcl	87	22
Simvastatin	Simvastatin	83	22
Tramadol Hcl	Tramadol Hcl	78	16
Valsartan	Valsartan	74	13
Enalapril Maleate	Enalapril Maleate	73	17
Carvedilol	Carvedilol	70	15
Fluticasone Propionate	Fluticasone Propionate	70	30
Propranolol Hcl	Propranolol Hcl	69	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	65	14
Alendronate Sodium	Alendronate Sodium	61	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	60	18
Warfarin Sodium	Warfarin Sodium	60	15
Alprazolam	Alprazolam	57	suppressed
Atenolol	Atenolol	56	suppressed
Benazepril Hcl	Benazepril Hcl	56	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	18
Finasteride	Finasteride	53	14
Pregabalin	Pregabalin	53	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	11
Venlafaxine Hcl Er	Venlafaxine Hcl	49	suppressed
Clopidogrel	Clopidogrel Bisulfate	42	14
Baclofen	Baclofen	41	suppressed
Pravastatin Sodium	Pravastatin Sodium	41	suppressed
Allopurinol	Allopurinol	39	12
Glipizide Er	Glipizide	39	suppressed
Trulicity	Dulaglutide	39	suppressed
Spiriva Handihaler	Tiotropium Bromide	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	38	25
Hydralazine Hcl	Hydralazine Hcl	36	12
Jardiance	Empagliflozin	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	15
Glipizide	Glipizide	35	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	34	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Irbesartan	Irbesartan	34	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Humalog Kwikpen U-100	Insulin Lispro	32	suppressed
Oxycodone Hcl	Oxycodone Hcl	31	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	11
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Incruse Ellipta	Umeclidinium Bromide	26	suppressed
Morphine Sulfate	Morphine Sulfate	26	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Ondansetron Odt	Ondansetron	24	13
Buspirone Hcl	Buspirone Hcl	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Bumetanide	Bumetanide	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	11
Prednisone	Prednisone	22	13
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Loperamide	Loperamide Hcl	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Nitroglycerin	Nitroglycerin	20	15
Torsemide	Torsemide	20	suppressed
Glimepiride	Glimepiride	18	suppressed
Cephalexin	Cephalexin	17	14
Dilt-Xr	Diltiazem Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Nystatin	Nystatin	15	14
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Estradiol	Estradiol	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Movantik	Naloxegol Oxalate	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Clotrimazole	Clotrimazole	12	12
Montelukast Sodium	Montelukast Sodium	12	suppressed
Ozempic	Semaglutide	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Insulin Lispro Protamine Mix	Insulin Lispro Protamin/Lispro	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error